This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Endologix's CEO Hosts Lazard Capital Markets 8th Annual Healthcare Conference Call Transcript

Endologix, Inc. ( ELGX)

Lazard Capital Markets 8th Annual Healthcare Conference Call

November 16, 2011 11:00 ET


John McDermott – President and Chief Executive Officer


Sean Lavin – Lazard Capital Markets


Sean Lavin – Lazard Capital Markets

[Starts Abruptly] He is going to give presentation and take questions. Thank you.

John McDermott – President and Chief Executive Officer

Okay, good morning everybody. Thanks Sean. Endologix is a medical device company located in Irvine, California. Very differentiated technology, which I’ll take you through in a minute, strong performing core business were one of the higher growth stories in Medtech, I think Q3 revenue growth of 25%, good growth better than 30% United States good gross margins. I’ll take you through both the core business as well as our pipeline, which is gained a lot of the attention over the last year.

So this is what we do. We repair abdominal aortic aneurysms, it’s a leading cause of death in the United States it’s an asymptomatic disease, which means you don’t know you have one unfortunately until it’s a serious problem. The historical way of treating aneurysm is the picture on the right open surgical repair, but over the last several years less-invasive therapies have been developed. And now most aneurysms are treated with catheter-based technology you see the illustration on the left.

So, we take a device in a catheter inserted in the groin guided up into and reline the aorta from the inside out. Therefore excluding the aneurysm from blood flow and preventing rupture and that’s the new technique represents over 60% of how AAA’s are fixed today. The primary limitation, the reason that more of them are fixed with this less-invasive therapy is that there are wide range of different anatomies, which the current technologies are unsuitable to treat.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs